Current anaesthesia and critical care最新文献_第9页

Sleep-disordered breathing and anaesthesia in the morbidly obese 病态肥胖患者的睡眠呼吸障碍和麻醉

Current anaesthesia and critical care Pub Date : 2010-02-01 DOI: 10.1016/j.cacc.2009.10.008

Jonathan Dakin , Michael Margarson

引用次数: 5

Airway management in obese patients 肥胖患者的气道管理

Current anaesthesia and critical care Pub Date : 2010-02-01 DOI: 10.1016/j.cacc.2009.09.004

John Myatt, Kevin Haire

引用次数: 12

Continuing professional development: Bariatric MCQs and self assesment 持续专业发展:减肥mcq和自我评估

Current anaesthesia and critical care Pub Date : 2010-02-01 DOI: 10.1016/j.cacc.2009.10.007

引用次数: 0

Anaesthetic considerations and management of the obese patient presenting for bariatric surgery 肥胖患者接受减肥手术的麻醉注意事项和处理

Current anaesthesia and critical care Pub Date : 2010-02-01 DOI: 10.1016/j.cacc.2009.10.006

Tanya O'Neill, Joanna Allam

引用次数: 33

Glycopeptide resistant enterococci: What's the problem? 糖肽耐药肠球菌:问题是什么?

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.07.001

G. Birgand

引用次数: 0

Case Scenario 的情况

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.08.001

引用次数: 0

Posterior reversible encephalopathy syndrome (PRES) in a patient of eclampsia with ‘partial’ HELLP syndrome presenting with status-epilepticus 后路可逆性脑病综合征(PRES)一例伴有“部分”HELLP综合征的子痫患者表现为癫痫持续状态

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.07.004

Harihar V. Hegde, Raghavendra P. Rao

引用次数: 8

Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain 评价药品上市后安全性:国家和国际药物警戒的描述，重点是用于慢性疼痛的药物

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.07.013

Ruth L. Savage , Desiree L. Kunac , Jeanette Johansson

{"title":"Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain","authors":"Ruth L. Savage , Desiree L. Kunac , Jeanette Johansson","doi":"10.1016/j.cacc.2009.07.013","DOIUrl":"10.1016/j.cacc.2009.07.013","url":null,"abstract":"<div><p>Clinicians play a key role in appraising the safety of medicines after marketing. A wide variety of adverse reactions and novel interactions may occur in individual patients. Formal reporting by prescribers and evaluation of their observations to allow timely communication of risk back to the end users is vital. Many countries have regional or national pharmacovigilance centres which contribute to the World Health Organization (WHO) Global Individual Case Safety Report (ICSR) database, VigiBase. We describe the role of pharmacovigilance in detecting and evaluating emerging evidence of adverse drug reactions, i.e. “signals” using the New Zealand Pharmacovigilance Centre as an example. The benefits to individual patient safety through a medical warning system are of particular relevance to anaesthetic practice. Effective and holistic pharmacovigilance relies on voluntary reporting systems for all therapeutic products, prescription or cohort event monitoring of selected medicines and vaccines, and specific monitoring of medication error. Ongoing development of computational methods for data-mining in the voluntary reporting databases for signal detection and the application of these methods to electronic longitudinal health care databases such as general practice records in order to detect, confirm or refute, and characterise signals of adverse drug reactions are also described.</p></div>","PeriodicalId":81055,"journal":{"name":"Current anaesthesia and critical care","volume":"20 5","pages":"Pages 215-220"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cacc.2009.07.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78528297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Neuropathic pain and drug safety MCQs and self-assessment 神经性疼痛与药物安全性mcq及自我评价

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.08.002

引用次数: 0

Complex regional pain syndrome – Mechanisms, diagnosis, and management 复杂的局部疼痛综合征-机制，诊断和管理

Current anaesthesia and critical care Pub Date : 2009-10-01 DOI: 10.1016/j.cacc.2009.07.012

Edward A. Shipton

{"title":"Complex regional pain syndrome – Mechanisms, diagnosis, and management","authors":"Edward A. Shipton","doi":"10.1016/j.cacc.2009.07.012","DOIUrl":"10.1016/j.cacc.2009.07.012","url":null,"abstract":"<div><p>Complex regional pain syndrome (CRPS) is a chronic neurological disorder characterized by regional disabling pain, increased sensitivity to tactile stimuli, swelling, vasomotor and sudomotor abnormality, and impairment of motor function. The disorder usually develops after minor trauma (contusions, sprains, and fractures) or surgery. No specific diagnostic test is available; hence, diagnosis is based mainly on history, clinical examination, and supportive laboratory findings. Evidence suggests that this interaction between peripheral and central systems arises from a number of sources including sympathetic–afferent coupling, re-organization of the central autonomic control, and changes in the somatomotor system and peripheral inflammation. Oral, topical, and intravenous medications targeting alpha-adrenergic receptors (clonidine) and the sympathetic nervous system have not been proven effective by Randomised Controlled Trials. The most commonly used agents, such as anticonvulsants, antidepressants, and opioids, have been found to be useful for other neuropathic pain conditions in large-scale trials but have not been adequately studied in CRPS. This article explores an interdisciplinary setting with comprehensive approach (pharmacological, interventional, and psychological in conjunction with rehabilitation pathway) as the protocol for the practical management of CRPS. Insight in predisposing factors may facilitate early diagnosis and elucidate underlying mechanisms that could provide targets for pharmacotherapy.</p></div>","PeriodicalId":81055,"journal":{"name":"Current anaesthesia and critical care","volume":"20 5","pages":"Pages 209-214"},"PeriodicalIF":0.0,"publicationDate":"2009-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cacc.2009.07.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88604926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 23